03.10.2024

Salmonellosis: 67 cases of salmonellosis were notified in Q1 2024, decreased from 84 in Q1 2023. Where travel history was known, 50% of cases were travel-associated and 50% were domestically acquired. Among domestic cases, infection with S. Typhimurium was more common, while infection with S. Enteritidis was more common among travel-associated cases. Three outbreaks of salmonellosis were notified in Q1 2024. The most frequently seen serotypes were S. Enteritidis (30%) and S. Typhimurium (28%). 8% of isolates were from bloodstream infections.
Campylobacteriosis: 733 cases of Campylobacteriosis notified in Q1 2024, similar to Q1 2023. One Campylobacter outbreak notified in Q1 2024. Lower than the number of outbreaks reported for the same time period in 2023 (n=4). 62 Campylobacter isolates were sequenced in the sentinel Campylobacter Reference Laboratory, representing approximately 8% of campylobacteriosis cases notified. 92% of isolates sequenced were C. jejuni.